Browse By: Country ι Category ι Latest Reports ι Tag

Vaccine Partnering Terms and Agreements

Pages » 1021
Published By » Current Partnering
Price » $2995
In stock
View Report Details
Description

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines   The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the lic... Click here for more details


Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010
GBI Research, the leading business intelligence provider, has released its latest research, Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010, which provides insights into the global vacc
Published Date: Aug 2011
Price: $3500
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
GBI Research, the leading business intelligence provider, has released its latest research, Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market, which provides insights into the global emerging c
Published Date: Oct 2011
Price: $3500
Vaccines - Africa
This package contains 4 vaccine market analyses from the following African countries: Ethiopia, Ghana, Morocco and Nigeria The vaccine market analyses give an overview of the actual situation, trends and future outlook of the vaccine markets in different African countries. The market ana
Published Date: Aug 2011
Price: $2018
Vaccines - America
This package contains 10 vaccine market analyses from the following American countries:  Canada, Chile, Colombia, Ecuador, Eritrea, Mexico, Panama, Peru, United States and Uruguay. The vaccine market analyses give an overview of the actual situation, trends and future outlook of the v
Published Date: Aug 2011
Price: $5269
Vaccines - Asia
This package contains 19 vaccine market analyses from the following Asian countries: Armenia, Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South Korea, Sri Lanka, Thailand and Turkey. The vaccine market
Published Date: Aug 2011
Price: $10009
Vaccines - Eastern Europe
This package contains 15 vaccine market analyses from the following Eastern European countries:  Bulgaria, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Poland and Ukraine The vaccine market analyses give an overview of the actual situation, tren
Published Date: Aug 2011
Price: $7842
Vaccines - Europe
This package contains 29 vaccine market analyses from the following European countries: Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal,
Published Date: Aug 2011
Price: $13396
Vaccines - Global
This package contains 63 vaccine market analyses from the following countries:  Austria, Belgium, Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the Netherlands, Norway, Poland, Portugal, Ro
Published Date: Aug 2011
Price: $27076
Vaccines - Western Europe
This package contains 14 vaccine market analyses from the following Western European countries:  Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden and United Kingdom. The vaccine market analyses give an overview of th
Published Date: Aug 2011
Price: $7301
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995

 


 

Related News

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Japan Promotes Higher Education to Improve the Skills of the Graduates
Shinzo Abe, the Prime Minister of Japan, is aiming to develop better-skilled graduates by retooling the public universities. The main motto is to transform the government-funded universities of Japan into scientific research centers, schools or global leaders. Japan’s Universities are planning to achieve this target by restructuring the curricula and redefining the missions. In June, all 86 of Japan’s national level universities were asked to submit their refined plans by the educ
Date: Aug 03

Hong Kong Ranked Fourth Amongst the 148 Most Popular Arbitral Venues
Cross-border investments, in the recent past, led to complex relations amongst the commercial parties. Commercial parties are moreover depending on the international arbitration to solve respective disputes. Hong Kong, for many reasons, is considered to be the most attractive arbitral venue in Asia Pacific.  As per the World Economic Forum Global Competitiveness Report, published for year 2013-2014, Hong Kong is ranked fourth amongst the 148 jurisdictions. Hong Kong is supposedly ahead o
Date: Aug 03

Slump in Oil and Gas Industry Taking Toll on Industry Economy
As the shippers, drivers, and airlines maintain to enjoy the lower fuel prices, the oil industry is broadly responding to extremely lower profits with high cuts in employment and spending. These cuts are affecting the economic growth.    Low gas and oil prices are beneficial for the overall economy. They help to reduce the costs for business and consumers. As the U.S. economic growth was extremely higher in the second quarter, the economists express that was partially boosted by the
Date: Aug 03

JX Holdings’ Sets its Summer Agenda toward Uproar in Oil Industry
The competition between companies in the global market is becoming more and more intense, day by day. The competition is growing both in domestic and overseas markets.  Yomiuri Shimbun, staff writer requested new leaders about their agenda for this summer. These leaders who took office at the top of the various companies this year were informed about the same.  Of all the companies, the star performer has reached the top and taken the stage. President Yukio Uchida, JX Holdings In
Date: Aug 03

HSBC Reports 10% Increase in Profit for 1st Half of 2015
HSBC Holdings has reported a rise in its profit for the first-half of 2015 by 10%. In a press note issued of Aug 03, 2015, the biggest bank in Europe has stated that the robust performance has helped the company to boost its revenue. In the same note, the bank has also announced the sale of its Brazilian unit for US$5.2 billion. The profit for H1 of 2015 has increased to 48 cents per share, summing up to US$13.6 billion in a whole, stated the bank. The revenue of the bank has increased by 4%
Date: Aug 03

China Plan to Tighten Regulations to Control Online Payment
China has plans to tighten the regulations that governs the country’s 270 online-payment enterprises such as Alibaba. This move has come as another blow to the flourishing Internet business for finance. Under the draft rules issued on July 31, 2015, the central bank is likely to limit the amount that a person can pay online through a third-party payment account to US$805 per day, crossing which, the customer would need to verify his/her identity via an electronic signature and security
Date: Aug 03

Walmart to Further Invest in E-commerce Business in China
The e-commerce market of China has not been a very easy one for Walmart to crack into, however the American retail giant is in no way giving in. On the contrary, Walmart has begun investing a lot more towards the e-commerce operations that it had initiated there, and in a way has taken total control of a particular China-based online retailer.  Walmart, on Thursday ended up purchasing the leftover shares of the Chinese company called Yihaodian. This was after it was seen that Walmart was
Date: Jul 31

Inflatable Device to Help Obese Patients Lose Weight gets FDA Approval
The United States Food and Drug Administration has given its approval for an inflatable device that can help patients suffering from obesity shed their weight without any surgeries. The balloon, made by Reshape Medical, will be inserted inside the body and fill a portion of the stomach.  A minimally invasive endoscopic procedure will be performed by doctors, where in they will go in through the mouth to reach the stomach and implant the device. Typically, the procedure will take less tha
Date: Jul 31

Upcoming Reports

DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. Whe
Published By: Transparency
Price: $4795
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers
Published By: Transparency
Price: $4795
Preventable Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
The use of preventable vaccines is to avoid the occurrence of an infectious disease, which is preventable by the use of vaccines. The occurrence of death due to a vaccine-preventable disease is termed as vaccine-preventable death, the reason being failure to attain vaccines in time, lack of access t
Published By: Transparency
Price: $4795